AstraZeneca's drug gets US FDA nod to treat lung disease patients

Topics AstraZeneca | US FDA | drugs

The US Food and Drug Administration approved AstraZeneca's drug to treat patients with a form of lung disease, the British drugmaker said on Friday.

The drug Breztri Aerosphere is being approved as a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), the third leading cause of death globally, AstraZeneca said. Known as "smoker's lung", COPD is a progressively worsening and potentially deadly condition that affects more than 380 million people worldwide, primarily caused by smoking,.....

This article is no longer available in our repository.

There could be multiple reasons for this.